CYP19A1 and prostate adenocarcinoma: To investigate the underlying mechanism by which the HeyL-aromatase axis regulates bicalutamide sensitivity, we conducted GSEA with HeyLHigh and HeyLLow prostate adenocarcinoma samples from the TCGA dataset and found that HeyL expression was positively correlated with signatures representative of autophagy regulation (Figure 6A).